DOCSLIB.ORG

Flaviviruses Versus the Host Cell, and Evolution in the Primate Interferon Response

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Flaviviruses Versus the Host Cell, and Evolution in the Primate Interferon Response Flaviviruses Versus the Host Cell, and Evolution in the Primate Interferon Response by Alison Ruth Gilchrist B.Sc., University of California at San Diego Athesissubmittedtothe Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Molecular Cellular and Developmental Biology 2020 Committee Members: Sara L. Sawyer, Chair Robert L. Garcea Rushika Perera Robin D. Dowell Sabrina L. Spencer ii Gilchrist, Alison Ruth (Ph.D., Molecular Cellular and Developmental Biology) Flaviviruses Versus the Host Cell, and Evolution in the Primate Interferon Response Thesis directed by Prof. Sara L. Sawyer Long-term interactions between viruses and their hosts often develop into genetic arms races, which result in fast-evolving proteins (i.e. proteins evolving under positive natural selection), especially in immune proteins. A bioinformatic screen of proteins in a component of the primate innate immune response, the interferon system, demonstrated that proteins farther downstream of interferon induction are more likely to be evolving under positive natural selection compared to proteins in interferon induction pathways. One of the proteins under positive selection in this screen, STING, is a known target of proteases from a group of viruses called flaviviruses. The human haplotypes of STING (three of which are studied in this work) demonstrate a range of phenotypes of antagonism and interferon induction that may help explain the evolutionary history of this crucial immune protein. The cleavage of STING demonstrates that the dengue virus protease targets host proteins for cleavage as well as viral proteins. In an attempt to identify novel targets of the dengue virus protease, a machine learning screen was used to predict possible motifs based on known motifs. This resulted in the identification of DGAT2, a newly described target of flavivirus proteases. The ability to cleave DGAT2, a host protein involved in maintaining lipid homeostasis, improves dengue virus replication, and is a conserved property of all flavivirus proteases tested. DGAT2 is not evolving under positive selection, making it a host-virus antagonistic interaction that has not resulted in an evolutionary arms race. However, identifying and describing this host-virus interaction helps us understand how dengue virus and other flaviviruses alter the host lipid environment during replication. Dedication For my parents. ”To know how much there is to know is the beginning of learning to live.” -Dorothy West (The Richer, the Poorer) iv Acknowledgements To Sara: thank you for setting up the support systems that propped me and my science up when we needed it, and for caring about the lab safety and organization that made being a bench scientist so fun. And thank you to Bob, Rushika, Robin, Sabrina, and one-time committee member David for being unfailingly kind, supportive, and helpful. Thank you to Nicholas Meyerson for being an unwavering hero. You helped me so much, for so long, that I will understand if you never want to speak to me again (but please do). Alex Stabell and Maryska Kaczmarek: thank you so much for welcoming me in to the lab, and for your help and friendship over the years. Thank you to Vanessa Bauer for being an incredible lab manager; I will never forgive you for setting an impossible standard. Thank you to Elena Judd for being a wonderful technician, and then an even more wonderful undergraduate researcher—you’re going to do great things in the future. Everyone else I met and worked with in the Sawyer Lab, including but not limited to: Cody Warren, Qing Yang, Camille Paige, Kyle Clark, Will Fattor, Arturo Barbachano-Guerrero, Joe Timpona, Emma Worden-Sapper, Sharon Wu, Obaiah Dirasantha: I’ll never forget any of you! And I can’t wait to check in on everyone over the coming years. Thanks to my mom for letting me cry over the phone so many times, and also for bragging about me so much, making it extremely hard to drop out of grad school. Thanks to my dad for helping me climb mountains, physical and metaphorical, my whole life. Thanks to Andrew and Daniel for nothing related to research, but everything related to sibling solidarity, and to Lena Meyer for being my not-a-sister sister, and an endless well of support and love when I needed it. Thank you to MCDB for a wonderful six years. To the entering MCDB class of 2014: I can’t v believe I was so lucky to spend my PhD with such wonderful classmates. To Adrian, Graycen, Julie, Daniel, Brad, Kate, and Abby: an extra special thank you for being part of what kept me sane. For every Science Bu↵, Nerd-Niter, and ComSciCon-RMW committee member I spent time with in the last six years: I hope I learned even a small portion of what you all have to teach scientists. To every other friend and colleague that I don’t have the space to thank: know that I appreciated you dearly and you helped get me through grad school. vi Contents Chapter 1 Introduction 1 1.1 Viruses and hosts in evolutionary combat . 1 1.2 Positiveselectionintheinterferonpathway . 4 1.3 STING: an immune protein that is a target of flavivirus proteases . 5 1.4 Using machine learning to predict new targets of flavivirus proteases . 6 1.5 DGAT2: a novel target of flavivirus proteases . 7 1.6 Thesis organization . 9 2 Positive selection in the interferon pathway 10 2.1 Positive natural selection . 10 2.2 Positiveselectioninimmunepathways . 11 2.3 Theinterferonresponse .................................. 12 2.4 Screening for positive selection in interferon pathways . 14 2.5 Characterization of multiple sequence alignments . 17 2.6 Interferon-stimulated genes experience more intense positive selection than interferon- induction genes or randomly-selected genes . 19 2.7 Discussion.......................................... 24 2.8 Methods........................................... 25 vii 3 STING: an immune protein that is a target of flavivirus proteases 30 3.1 Flaviviruses, and dengue viruses in particular, are world-wide pathogens with major consequences for human health . 30 3.2 Human STING and the interferon response . 32 3.3 Human STING, but not human 78Q STING, is cleaved by multiple flaviviruses . 33 3.4 RodentSTINGisunderpositiveselection . 41 3.5 The interferon response is stimulated by STING transfection . 42 3.6 Active dengue virus protease inhibits interferon production . 44 3.7 Small di↵erences in virus replication in cell lines expressing di↵erent STING alleles . 47 3.8 Not all flavivirus proteases inhibit the STING-dependent interferon response . 49 3.9 Discussion.......................................... 49 3.10Methods........................................... 53 4 DGAT2: a novel target of flavivirus proteases identified by machine learning 57 4.1 Predicting targets of the dengue virus protease by machine learning . 57 4.2 DGATiscleavedbythedenguevirusprotease . 63 4.3 Mutation of the DGAT2 cleavage motif reduces viral infection. 65 4.4 Confirmation with DGAT2 KO A549s . 73 4.5 ChemicallyinhibitingDGAT2activity . 74 4.6 Cleavage of DGAT2 is conserved in the flavivirus family. 77 4.7 The cleavage of DGAT2: discussion . 79 4.8 Attempted further validation of the machine learning approach to predicting targets offlavivirusproteases ................................... 81 4.9 Methods........................................... 92 5 Conclusion 100 viii Bibliography 102 Appendix A Genes Analyzed in the Interferon Positive Selection Screen 113 B Host Proteins Predicted by Machine Learning 126 ix Tables Table 2.1 Many interferon genes are known to be evolving under positive selection. 13 2.2 Genes in the interferon induction pathway and genes stimulated by interferon evolv- ingunderpositiveselection. .. 26 x Figures Figure 1.1 An example of the arms race between virus and host proteins . 3 1.2 DGAT2Biochemistry ................................... 8 2.1 Simplified diagram of the interferon response. 16 2.2 Quality and equity metrics for the three families of multiple sequence alignments compared........................................... 18 2.3 Characterization of multiple species alignments . 21 2.4 Interferon-stimulated genes have a higher whole-gene dN/dS value than other genes, and have more codons under positive selection than other genes. 23 3.1 DengueviruscleavesSTINGduringinfection . 34 3.2 The SNPs of HAQ STING are geographically distinct . 36 3.3 The 78Q SNP prevents cleavage of human STING . 38 3.4 DENV2 cleaves STING and HAQ STING, but not 78Q STING . 39 3.5 Most flaviviruses cleave STING and HAQ STING, but not 78Q STING . 40 3.6 Rodent Sting1 is under positive selection, but only in the Hystricomorpha clade. 43 3.7 Transfecting STING induces interferon production . 45 3.8 Transfecting STING and DENV2 protease dampens interferon production. 46 3.9 STING SNPs and protease antagonism. 48 3.10 Non-cleavable STING reduces DENV2 replication in A549s. 50 xi 3.11 STING alleles and flavivirus protease antagonism. 51 3.12 STING alleles and flavivirus protease antagonism, part 2. 52 4.1 The dengue virus polyprotein is cleaved by the dengue virus protease. 60 4.2 Schematic of the machine learning protocol. 62 4.3 DGAT2 motif identified and the structure of DGAT2. 64 4.4 DGAT2iscleavedbythedenguevirusprotease. 66 4.5 DGAT2 cleavage product not significantly degraded by the proteasome . 67 4.6 Wild-type A549 cells complemented with mutant DGAT2 did not inhibit dengue virusreplication. ...................................... 69 4.7 Endogenous DGAT2 is significantly reduced after transfection of DGAT2-targeting siRNA............................................. 70 4.8 Non-cleavable DGAT2 reduces DENV2 replication. 72 4.9 The presence of non-cleavable DGAT2 inhibits dengue replication in DGAT2 knock- outcells............................................ 75 4.10 DGAT2 inhibition in DGAT2 mutant cell lines did not result in significantly higher denguevirusreplication................................... 76 4.11 DGAT2 cleaved by all tested flavivirus proteases . 78 4.12 Proposed model for flavivirus cleavage of DGAT2 . 80 4.13 Example screening of predicted host proteins by western blotting. 83 4.14 The vast majority of predicted proteins were not cleaved by the dengue virus protease.
Load more

Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
    [Show full text]
  • Chromosomal Aberrations in Head and Neck Squamous Cell Carcinomas in Norwegian and Sudanese Populations by Array Comparative Genomic Hybridization
    825-843 12/9/08 15:31 Page 825 ONCOLOGY REPORTS 20: 825-843, 2008 825 Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization ERIC ROMAN1,2, LEONARDO A. MEZA-ZEPEDA3, STINE H. KRESSE3, OLA MYKLEBOST3,4, ENDRE N. VASSTRAND2 and SALAH O. IBRAHIM1,2 1Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Jonas Lies vei 91; 2Department of Oral Sciences - Periodontology, Faculty of Medicine and Dentistry, University of Bergen, Årstadveien 17, 5009 Bergen; 3Department of Tumor Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo; 4Department of Molecular Biosciences, University of Oslo, Blindernveien 31, 0371 Oslo, Norway Received January 30, 2008; Accepted April 29, 2008 DOI: 10.3892/or_00000080 Abstract. We used microarray-based comparative genomic logical parameters showed little correlation, suggesting an hybridization to explore genome-wide profiles of chromosomal occurrence of gains/losses regardless of ethnic differences and aberrations in 26 samples of head and neck cancers compared clinicopathological status between the patients from the two to their pair-wise normal controls. The samples were obtained countries. Our findings indicate the existence of common from Sudanese (n=11) and Norwegian (n=15) patients. The gene-specific amplifications/deletions in these tumors, findings were correlated with clinicopathological variables. regardless of the source of the samples or attributed We identified the amplification of 41 common chromosomal carcinogenic risk factors. regions (harboring 149 candidate genes) and the deletion of 22 (28 candidate genes). Predominant chromosomal alterations Introduction that were observed included high-level amplification at 1q21 (harboring the S100A gene family) and 11q22 (including Head and neck squamous cell carcinoma (HNSCC), including several MMP family members).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Proteomic Expression Profile in Human Temporomandibular Joint
    diagnostics Article Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction Andrea Duarte Doetzer 1,*, Roberto Hirochi Herai 1 , Marília Afonso Rabelo Buzalaf 2 and Paula Cristina Trevilatto 1 1 Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba 80215-901, Brazil; [email protected] (R.H.H.); [email protected] (P.C.T.) 2 Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru 17012-901, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-41-991-864-747 Abstract: Temporomandibular joint dysfunction (TMD) is a multifactorial condition that impairs human’s health and quality of life. Its etiology is still a challenge due to its complex development and the great number of different conditions it comprises. One of the most common forms of TMD is anterior disc displacement without reduction (DDWoR) and other TMDs with distinct origins are condylar hyperplasia (CH) and mandibular dislocation (MD). Thus, the aim of this study is to identify the protein expression profile of synovial fluid and the temporomandibular joint disc of patients diagnosed with DDWoR, CH and MD. Synovial fluid and a fraction of the temporomandibular joint disc were collected from nine patients diagnosed with DDWoR (n = 3), CH (n = 4) and MD (n = 2). Samples were subjected to label-free nLC-MS/MS for proteomic data extraction, and then bioinformatics analysis were conducted for protein identification and functional annotation. The three Citation: Doetzer, A.D.; Herai, R.H.; TMD conditions showed different protein expression profiles, and novel proteins were identified Buzalaf, M.A.R.; Trevilatto, P.C.
    [Show full text]
  • OR2A5 (NM 012365) Human Tagged ORF Clone – RC220078L3
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC220078L3 OR2A5 (NM_012365) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: OR2A5 (NM_012365) Human Tagged ORF Clone Tag: Myc-DDK Symbol: OR2A5 Synonyms: OR2A8; OR2A11P; OR2A26; OR7-138; OR7-141 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC220078). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_012365 ORF Size: 933 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 OR2A5 (NM_012365) Human Tagged ORF Clone – RC220078L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_012365.1, NP_036497.1 RefSeq Size: 936 bp RefSeq ORF: 936 bp Locus ID: 393046 UniProt ID: Q96R48, A0A126GW49 Protein Pathways: Olfactory transduction MW: 35 kDa Gene Summary: Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell.
    [Show full text]
  • RASEF Expression Correlates with Hormone Receptor Status in Breast Cancer
    ONCOLOGY LETTERS 16: 7223-7230, 2018 RASEF expression correlates with hormone receptor status in breast cancer MASAHIRO SHIBATA1, MITSURO KANDA2, DAI SHIMIZU2, HARUYOSHI TANAKA2, SHINICHI UMEDA2, TAKASHI MIWA2, MASAMICHI HAYASHI2, TAKAHIRO INAISHI1, NORIYUKI MIYAJIMA1, YAYOI ADACHI1, YUKO TAKANO1, KENICHI NAKANISHI1, DAI TAKEUCHI1, SUMIYO NODA1, YASUHIRO KODERA2 and TOYONE KIKUMORI1 Departments of 1Breast and Endocrine Surgery (Surgery II) and 2Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan Received February 26, 2018; Accepted September 25, 2018 DOI: 10.3892/ol.2018.9542 Abstract. Breast cancer (BC) is the most frequently estrogen receptor status (P<0.001), negative progesterone diagnosed malignant tumor in women worldwide, and the receptor status (P<0.001), and triple-negative status (P<0.001). development of new molecules associated with BC is essential Additionally, although the differences were not statistically for the management of this disease. RAS and EF-hand significant, patients with low RASEF expression levels domain-containing (RASEF) encodes the GTPase enzyme exhibited poorer disease-free survival (P=0.123) and overall that belongs to the Rab family. Although the effects of this survival (P=0.086) than other patients. The results of the gene have been reported in several malignant tumor types, the present study indicate that RASEF mRNA expression levels role of RASEF in BC has not been completely elucidated. The are associated with hormone receptor status in BC. aim of the present study was to investigate the importance of RASEF expression in BC. RASEF mRNA expression levels Introduction were evaluated in BC and non-cancerous mammary cell lines.
    [Show full text]
  • Multiple Loci Modulate Opioid Therapy Response for Cancer Pain
    Published OnlineFirst May 27, 2011; DOI: 10.1158/1078-0432.CCR-10-3028 Clinical Cancer Predictive Biomarkers and Personalized Medicine Research Multiple Loci Modulate Opioid Therapy Response for Cancer Pain Antonella Galvan1, Frank Skorpen2,Pal Klepstad2,3, Anne Kari Knudsen2, Torill Fladvad2, Felicia S. Falvella1, Alessandra Pigni1, Cinzia Brunelli1, Augusto Caraceni1,2, Stein Kaasa2,4, and Tommaso A. Dragani1 Abstract Purpose: Patients treated with opioid drugs for cancer pain experience different relief responses, raising the possibility that genetic factors play a role in opioid therapy outcome. In this study, we tested the hypothesis that genetic variations may control individual response to opioid drugs in cancer patients. Experimental Design: We tested 1 million single-nucleotide polymorphisms (SNP) in European cancer patients, selected in a first series, for extremely poor (pain relief 40%; n ¼ 145) or good (pain relief 90%; n ¼ 293) responses to opioid therapy using a DNA-pooling approach. Candidate SNPs identified by SNP- array were genotyped in individual samples constituting DNA pools as well as in a second series of 570 patients. Results: Association analysis in 1,008 cancer patients identified eight SNPs significantly associated with À pain relief at a statistical threshold of P < 1.0 Â 10 3, with rs12948783, upstream of the RHBDF2 gene, À showing the best statistical association (P ¼ 8.1 Â 10 9). Functional annotation analysis of SNP-tagged genes suggested the involvement of genes acting on processes of the neurologic system. Conclusion: Our results indicate that the identified SNP panel can modulate the response of cancer patients to opioid therapy and may provide a new tool for personalized therapy of cancer pain.
    [Show full text]
  • Genomic and Transcriptome Analysis Revealing an Oncogenic Functional Module in Meningiomas
    Neurosurg Focus 35 (6):E3, 2013 ©AANS, 2013 Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas XIAO CHANG, PH.D.,1 LINGLING SHI, PH.D.,2 FAN GAO, PH.D.,1 JONATHAN RUssIN, M.D.,3 LIYUN ZENG, PH.D.,1 SHUHAN HE, B.S.,3 THOMAS C. CHEN, M.D.,3 STEVEN L. GIANNOTTA, M.D.,3 DANIEL J. WEISENBERGER, PH.D.,4 GAbrIEL ZADA, M.D.,3 KAI WANG, PH.D.,1,5,6 AND WIllIAM J. MAck, M.D.1,3 1Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; 2GHM Institute of CNS Regeneration, Jinan University, Guangzhou, China; 3Department of Neurosurgery, Keck School of Medicine, University of Southern California, Los Angeles, California; 4USC Epigenome Center, Keck School of Medicine, University of Southern California, Los Angeles, California; 5Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, California; and 6Division of Bioinformatics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California Object. Meningiomas are among the most common primary adult brain tumors. Although typically benign, roughly 2%–5% display malignant pathological features. The key molecular pathways involved in malignant trans- formation remain to be determined. Methods. Illumina expression microarrays were used to assess gene expression levels, and Illumina single- nucleotide polymorphism arrays were used to identify copy number variants in benign, atypical, and malignant me- ningiomas (19 tumors, including 4 malignant ones). The authors also reanalyzed 2 expression data sets generated on Affymetrix microarrays (n = 68, including 6 malignant ones; n = 56, including 3 malignant ones).
    [Show full text]
  • Sex-Specific Transcriptome Differences in Human Adipose
    G C A T T A C G G C A T genes Article Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells 1, 2, 3 1,3 Eva Bianconi y, Raffaella Casadei y , Flavia Frabetti , Carlo Ventura , Federica Facchin 1,3,* and Silvia Canaider 1,3 1 National Laboratory of Molecular Biology and Stem Cell Bioengineering of the National Institute of Biostructures and Biosystems (NIBB)—Eldor Lab, at the Innovation Accelerator, CNR, Via Piero Gobetti 101, 40129 Bologna, Italy; [email protected] (E.B.); [email protected] (C.V.); [email protected] (S.C.) 2 Department for Life Quality Studies (QuVi), University of Bologna, Corso D’Augusto 237, 47921 Rimini, Italy; [email protected] 3 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Via Massarenti 9, 40138 Bologna, Italy; fl[email protected] * Correspondence: [email protected]; Tel.: +39-051-2094114 These authors contributed equally to this work. y Received: 1 July 2020; Accepted: 6 August 2020; Published: 8 August 2020 Abstract: In humans, sexual dimorphism can manifest in many ways and it is widely studied in several knowledge fields. It is increasing the evidence that also cells differ according to sex, a correlation still little studied and poorly considered when cells are used in scientific research. Specifically, our interest is on the sex-related dimorphism on the human mesenchymal stem cells (hMSCs) transcriptome. A systematic meta-analysis of hMSC microarrays was performed by using the Transcriptome Mapper (TRAM) software. This bioinformatic tool was used to integrate and normalize datasets from multiple sources and allowed us to highlight chromosomal segments and genes differently expressed in hMSCs derived from adipose tissue (hADSCs) of male and female donors.
    [Show full text]
  • The Mutational Landscape of Human Olfactory G Protein-Coupled Receptors
    Jimenez et al. BMC Biology (2021) 19:21 https://doi.org/10.1186/s12915-021-00962-0 RESEARCH ARTICLE Open Access The mutational landscape of human olfactory G protein-coupled receptors Ramón Cierco Jimenez1,2, Nil Casajuana-Martin1, Adrián García-Recio1, Lidia Alcántara1, Leonardo Pardo1, Mercedes Campillo1 and Angel Gonzalez1* Abstract Background: Olfactory receptors (ORs) constitute a large family of sensory proteins that enable us to recognize a wide range of chemical volatiles in the environment. By contrast to the extensive information about human olfactory thresholds for thousands of odorants, studies of the genetic influence on olfaction are limited to a few examples. To annotate on a broad scale the impact of mutations at the structural level, here we analyzed a compendium of 119,069 natural variants in human ORs collected from the public domain. Results: OR mutations were categorized depending on their genomic and protein contexts, as well as their frequency of occurrence in several human populations. Functional interpretation of the natural changes was estimated from the increasing knowledge of the structure and function of the G protein-coupled receptor (GPCR) family, to which ORs belong. Our analysis reveals an extraordinary diversity of natural variations in the olfactory gene repertoire between individuals and populations, with a significant number of changes occurring at the structurally conserved regions. A particular attention is paid to mutations in positions linked to the conserved GPCR activation mechanism that could imply phenotypic variation in the olfactory perception. An interactive web application (hORMdb, Human Olfactory Receptor Mutation Database) was developed for the management and visualization of this mutational dataset.
    [Show full text]
  • Sean Raspet – Molecules
    1. Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Molecular weight: 240.39 g/mol Volume (cubic Angstroems): 258.88 Atoms number (non-hydrogen): 17 miLogP: 4.43 Structure: Biological Properties: Predicted Druglikenessi: GPCR ligand -0.23 Ion channel modulator -0.03 Kinase inhibitor -0.6 Nuclear receptor ligand 0.15 Protease inhibitor -0.28 Enzyme inhibitor 0.15 Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Predicted Olfactory Receptor Activityii: OR2L13 83.715% OR1G1 82.761% OR10J5 80.569% OR2W1 78.180% OR7A2 77.696% 2. Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Molecular weight: 239.36 Volume (cubic Angstroems): 252.83 Atoms number (non-hydrogen): 17 miLogP: 4.33 Structure: Biological Properties: Predicted Druglikeness: GPCR ligand -0.6 Ion channel modulator -0.41 Kinase inhibitor -0.93 Nuclear receptor ligand -0.17 Protease inhibitor -0.39 Enzyme inhibitor 0.01 Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Predicted Olfactory Receptor Activity: OR52D1 71.900% OR1G1 70.394% 0R52I2 70.392% OR52I1 70.390% OR2Y1 70.378% 3. Commercial name: Hyperflor© IUPAC Name: 2-benzyl-1,3-dioxan-5-one SMILES: O=C1COC(CC2=CC=CC=C2)OC1 Molecular weight: 192.21 g/mol Volume
    [Show full text]
  • Characterization of the Golgi C10orf76-PI4KB Complex, and Its
    bioRxiv preprint doi: https://doi.org/10.1101/634592; this version posted May 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Characterization of the Golgi c10orf76-PI4KB complex, and its 2 necessity for Golgi PI4P levels and enterovirus replication 3 4 McPhail, J.A.1, Lyoo, H.R.2*, Pemberton, J.G.3*, Hoffmann, R.M.1, van Elst W.2, 5 Strating J.R.P.M.2, Jenkins, M.L.1, Stariha, J.T.B.1, van Kuppeveld, F.J.M.2#, Balla., T.3#, and 6 Burke, J.E.1# 7 * - These authors contributed equally 8 # - Corresponding authors 9 10 Affiliations 11 1 Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, 12 Canada 13 2 Department of Infectious Diseases & Immunology, Virology Division, Faculty of 14 Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. 15 3 Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute 16 of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 17 USA 18 19 Corresponding authors: 20 Burke, John E. ([email protected]), Tel: 1-250-721-8732 21 Balla, Tamas ([email protected]), Tel: 301-435-5637 22 van Kuppeveld, Frank J.M. ([email protected]), Tel: 31-30-253-4173 23 24 Running title 25 Role of c10orf76-PI4KB at the Golgi 26 27 28 29 30 31 32 bioRxiv preprint doi: https://doi.org/10.1101/634592; this version posted May 10, 2019.
    [Show full text]